Clinical Trial Update: Long-Term Therapy With Ribavirin for Chronic Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update noting the completion of long-term ribavirin therapy for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED